<p>Induction of vulval fates in the C. elegans hermaphrodite is mediated by a conserved RTK/Ras/MAP kinase signalling pathway, in which the core components can be placed into a linear genetic and biochemical pathway. However, the events that occur downstream of this pathway are not yet well understood. This thesis describes studies on three genes, lin-1, lin-25 and sur-2 that function genetically downstream of the RTK/Ras/MAP kinase pathway in vulva induction. lin-1 encodes an ETS protein that appears to be a direct target of the RTK/Ras/MAP kinase pathway during the induction of vulval fates. To understand more in detail how Ras signalling in C. elegans affects cell fate specification we have analysed the effects of lin-1 mutations on various Ras-mediated cell fate specification events. Our results show that lin-1, besides its function in vulval induction, functions in most other Ras-mediated cell fate specification events in C. elegans, and that lin-1 appears to have a negative function in a majority of these events. Two other genes, lin-25 and sur-2, also function genetically downstream of the RTK/Ras/MAP kinase pathway during induction of vulval fates. Previously, two different models have been proposed for the function of these genes (I) that they function together with a gene in the homeotic cluster to specify the identity of the vulval precursor cells or (II) that they constitute components of the RTK/Ras/MAP kinase signalling pathway. To help clarify the role of lin-25 and sur-2, we have caried out studies of the effects of lin-25 and sur-2 mutations on other cells in the worm in which the RTK/Ras/MAP kinase pathway functions. The results exclude the possibility that lin-25 and sur-2 solely function in vulva induction and suggest that the two genes are intimately involved in Ras-mediated signalling. In addition we show that the major focus for lin-25 during vulval induction is in the vulva precursor cells themselves. Furthermore, results presented here suggest that LIN-25 and SUR-2 function together in the same process in the cell. We show here by both genetic and immunological experiments that LIN-25 is associated with Mediator in C. elegans, a multiprotein complex required for transcriptional regulation. Taken together, these results suggest that lin-25 and sur-2 function in regulating transcription of genes in response to Ras signalling.</p>

Induction of vulval fates in the C. elegans hermaphrodite is mediated by a conserved RTK/Ras/MAP kinase signalling pathway, in which the core components can be placed into a linear genetic and biochemical pathway. However, the events that occur downstream of this pathway are not yet well understood. This thesis describes studies on three genes, lin-1, lin-25 and sur-2 that function genetically downstream of the RTK/Ras/MAP kinase pathway in vulva induction. lin-1 encodes an ETS protein that appears to be a direct target of the RTK/Ras/MAP kinase pathway during the induction of vulval fates. To understand more in detail how Ras signalling in C. elegans affects cell fate specification we have analysed the effects of lin-1 mutations on various Ras-mediated cell fate specification events. Our results show that lin-1, besides its function in vulval induction, functions in most other Ras-mediated cell fate specification events in C. elegans, and that lin-1 appears to have a negative function in a majority of these events. Two other genes, lin-25 and sur-2, also function genetically downstream of the RTK/Ras/MAP kinase pathway during induction of vulval fates. Previously, two different models have been proposed for the function of these genes (I) that they function together with a gene in the homeotic cluster to specify the identity of the vulval precursor cells or (II) that they constitute components of the RTK/Ras/MAP kinase signalling pathway. To help clarify the role of lin-25 and sur-2, we have caried out studies of the effects of lin-25 and sur-2 mutations on other cells in the worm in which the RTK/Ras/MAP kinase pathway functions. The results exclude the possibility that lin-25 and sur-2 solely function in vulva induction and suggest that the two genes are intimately involved in Ras-mediated signalling. In addition we show that the major focus for lin-25 during vulval induction is in the vulva precursor cells themselves. Furthermore, results presented here suggest that LIN-25 and SUR-2 function together in the same process in the cell. We show here by both genetic and immunological experiments that LIN-25 is associated with Mediator in C. elegans, a multiprotein complex required for transcriptional regulation. Taken together, these results suggest that lin-25 and sur-2 function in regulating transcription of genes in response to Ras signalling.

El treball que es presenta en aquesta tesi pretén contribuir al camp de la ciència de superfícies biològiques, amb el desenvolupament de superfícies adaptades amb cadenes lateral reactives per tal de unir covalentment biomolècul·les d'interès a la superfície.La polimerització assistida per plasma del recobriments actius és un mètode atractiu per tal d'obtenir cadenes laterals reactives, mitjançant pel·lícules nanomètriques amb densitats de grups funcionals adaptats. Sota control de les condicions experimentals, l'estructura del dipòsit polimèric es pot control i les estructures químiques obtingudes poden variar des de xarxes polimèriques altament funcionalitzades amb baixa reticulació fins a xarxes altament reticulades amb baix contingut funcional. La recerca descrita en aquesta tesi tracta de la modificació de superfície de diversos substrats per polimerització de plasma. La part essencial del treball es dirigeix cap al funcionalització amb grups èster de pentafluorofenil a la superfície, durant la polimerització per grafting i polimerització de plasma pulsat de pentafluofenil metacrilat. Aquesta classe de grup làbil és de gran interès per a la seva fàcil reactivitat amb molècules amb mines terminals, com pèptids. Altres monòmers comercials també s'han emprat al començament de l'estudi, com a primera aproximació a les tècniques de plasma. La caracterització d'aquestes superfícies s'ha fet a través de tècniques analítiques com FTIR, XPS, AFM o ToF - SIMS entre d'altres.A més, s'ha dut a terme un estudi per fer a mida el polímer de PFM per a millorar la retenció de la seva estructura, i així com un estudi profund de la seva reactivitat davant de molècules amb amines terminals diferents d'interès, afegint SPR o l'aplicació de sensors microcantiliver a les tècniques de caracterització per aconseguir una millor comprensió de la química i cinètica de la reacció.Sobre el propòsit d'aconseguir superfícies funcionalitzades útils, s'ha realitzat un patterning de les superfícies amb l'ús de màscares per a capa selectiva de les mostres per controlar les àrees modificades. Això s'ha fet per a l'aplicació d'aquesta pel·lícula a dispositius reals, així com a prova de la seva biocompatibilitat per cultiu cel·lular i per assaigs in vivo. / El trabajo que se presenta en esta tesis pretende contribuir al campo de la ciencia de superficies biológicas, con el desarrollo de superficies adaptadas con cadenas lateral reactivas con el fin de unir covalentemente biomoléculas de interés a la superficie.La polimerización asistida por plasma de recubrimientos activos es un método atractivo con el fin de obtener cadenas laterales reactivas, mediante películas nanométricas con densidades de grupos funcionales adaptados. Bajo control de las condiciones experimentales, la estructura del depósito polimérico se puede control y las estructuras químicas obtenidas pueden variar desde redes poliméricas altamente funcionalitzadas con baja reticulación hasta redes altamente reticuladas con bajo contenido funcional.La investigación descrita en esta tesis trata de la modificación de superficie de diversos sustratos por polimerización de plasma. La parte esencial del trabajo se dirige hacia el funcionalización con grupos éster de pentafluorofenilo en la superficie, durante la polimerización por grafting y polimerización de plasma pulsado de pentafluofenilmetacrilato. Esta clase de grupo lábil es de gran interés para su fácil reactividad con moléculas con minas terminales, como péptidos. Otros monómeros comerciales también se han servido al principio del estudio, como primera aproximación a las técnicas de plasma. La caracterización de estas superficies se ha hecho a través de técnicas analíticas como FTIR, XPS, AFM o ToF - SIMS entre otros. Además, se ha llevado a cabo un estudio para hacer a medida el polímero de PFM para mejorar la retención de su estructura, y así como un estudio profundo de su reactividad delante de moléculas con aminas terminales diferentes de interés, añadiendo SPR o la aplicación de sensores microcantiliver a las técnicas de caracterización para conseguir una mejor comprensión de la química y cinética de la reacción.Sobre el propósito de conseguir superficies funcionalizadas útiles, se ha realizado un patterning de las superficies con el uso de máscaras para capa selectiva de las muestras para controlar las áreas modificadas. Eso se ha hecho para la aplicación de esta película en dispositivos reales, así como a prueba de su biocompatibillidad por cultivo celular y para ensayos in vivo. / The work presented in this thesis has the main aim to contribute in the field of biological surface science, by developing tailored surfaces with reactive side chains in order to attach desired biomolecules to the surface by a covalent link. Plasma polymerization of surface active coatings is an attractive method to obtain reactive side chains, by making nanometer thick films of tailored functional group densities. By controlling the experimental conditions, the structure of the polymer deposit can be largely controlled and the chemical structures obtained can range from highly functional polymer networks of low cross link density to polymer networks of low functional group but high cross link densities. The research described in this thesis deals with the surface modification of various substrates by plasma polymerization. The major part of the work is directed towards the funtionalization with pentafluorophenyl ester groups on the surface, through the grafting polymerization and pulsed plasma polymerization of pentafluophenyl methacrylate. This kind of labile group is of high interest for its easy reactivity to amino terminated molecules, such as peptides. Other commercial monomers were also used at the beginning of the study, as a first approach to the plasma techniques. The characterization of these surfaces is done through several analytical techniques as FTIR, XPS, AFM or ToF-SIMS among others. Furthermore, a study for tailoring the PFM polymer for better structure retention and deep study of its reactivity in front of different amino terminated molecules of interest was performed, adding SPR or the implementation of microcantilever sensors to the characterization techniques to achieve a better understanding of the chemistry and kinetic of the reaction, in order to achieve the best peptide binding for reliable well characterized bioactive interface..On the aim of achieving useful functionalized surfaces, a patterning of the surfaces with the use of masks for selective coating of the samples has been performed to control the modified areas. This has been done for application of this film to real devices, as well as to test of its biocompatibility by cell culture and in vivo assays.

Notre laboratoire a démontré que la capacité proinflammatoire du vascular endothelial growth factor (VEGF-A165) implique la synthèse endothéliale du facteur d’activation plaquettaire (PAF) via l’activation du récepteur tyrosine kinase homodimérique VEGFR-2/R-2. La synthèse du PAF requiert l’activation de la p38 MAPK et p42/44 MAPK qui activent la phospholipase A2 secrétée de type V (sPLA2-V). Nous avons découvert que la synthèse aigue de prostacycline (PGI2) induite par le VEGF-A165 requiert l’activation des récepteurs hétérodimériques VEGFR-1/R-2. L’activation sélective des récepteurs du VEGF peut donc agir comme balance dans la synthèse de facteurs pro-(PAF) et anti-(PGI2) inflammatoire. Cependant, les tyrosines impliquées dans la transphosphorylation de VEGFR-2/R-2 menant à la synthèse du PAF sont inconnues. Par mutagenèse dirigée, nous avons effectué des transfections transitoires de cellules endothéliales avec des plasmides codant pour le VEGFR-2 dont les tyrosines ciblées ont été remplacées de façon séquentielle par une phénylalanine. Un vecteur vide pcDNA a été utilisé comme contrôle négatif. La stimulation des cellules endothéliales de l’aorte bovine (BAEC) transfectées avec le VEGF-A165 (1nM) pendant 15 minutes augmente la synthèse du PAF de 300%, laquelle était similaire dans les BAEC non transfectées. Dans les BAEC transfectées avec les vecteurs pcDNA codant pour les mutations Y801F, Y1059F, Y1175F et Y1214F, nous avons observé une réduction de 54, 73, 68, et 57% respectivement de la synthèse du PAF induite par le VEGF par rapport au pcDNA témoin. Nos résultats apportent un nouvel aperçu sur le mécanisme par lequel le VEGF induit la synthèse du PAF qui est connu pour sa contribution dans l’activité pro-inflammatoire du VEGF. / Vascular endothelial growth factor (VEGF) inflammatory effects require acute platelet-activating factor (PAF) synthesis by endothelial cells (EC). We reported that VEGF-mediated PAF synthesis involves the activation of the homodimeric tyrosine kinase receptor VEGFR-2/R-2 which is leading to p38 and p42/44 mitogen-activated protein kinases (MAPKs) and secreted group V phospholipase A2 (sPLA2-V) activation. We also reported that VEGF-A165-mediated prostacyclin (PGI2) synthesis requires VEGFR-1/R-2 heterodimeric receptor activation. Selective activation of VEGF receptors can thus act as a balance in the synthesis of pro-(PAF) and anti-(PGI2) inflammatory factors. It is unknown which VEGFR-2 tyrosine phosphorylation site(s) contribute(s) to PAF synthesis. Bovine aortic endothelial cells (BAEC) were transfected with pcDNA vectors encoding for native VEGF receptor-2 (VEGFR-2) cDNA, or tyrosine phosphorylation sites mutated into phenylalanine (Y801F), (Y1059F), (Y1175F), (Y1214F), and an empty pcDNA vector was used as negative control. Treatment of pcDNA-transfected BAEC with VEGF-A165 (1nM) for 15 minutes increased PAF synthesis by 300%, which was similar to VEGF-mediated PAF synthesis in untransfected BAEC. In BAEC transfected with pcDNA vectors encoding mutated Y801F, Y1059F, Y1175F or Y1214F VEGFR-2 cDNA, we observed a marked reduction of VEGF-mediated PAF synthesis by 54, 73, 68 and 57% respectively as compared to pcDNA-transfected BAEC. Our current data provide novel insight on the mechanisms by which VEGF promotes endothelial PAF synthesis which is known to contribute to VEGF pro-inflammatory activities.

Les cellules souches embryonnaires (ES) sont porteuses de grands espoirs en recherche biomédicale dans le but d’apporter un traitement définitif à l’ostéoarthrose. Parce que certaines articulations des chevaux sont similaires à celles des humains, cet animal représente un modèle important dans l’évaluation de stratégies de régénération du cartilage. Cependant, pour expérimenter un traitement par les cellules ES chez le cheval, des cellules ES équines (eES) n’ont toujours pas pu être dérivées. Dans ce contexte, l’objectif principal de cette étude est de dériver des lignées de cellules eES. Le premier objectif de notre étude consiste à optimiser la technique de dérivation des cellules eES. Nous démontrons que la lignée de cellules nourricières et le stade de développement des embryons influencent l’efficacité de la technique de dérivation tandis que l’inhibition de voies de signalisation menant à la différenciation des cellules ES ne l’influence pas sous nos conditions. Le deuxième objectif de notre étude est de caractériser de façon plus approfondie les lignées de cellules eES obtenues. Nous démontrons que les cellules eES dérivées expriment autant des marqueurs associés aux cellules pluripotentes qu’aux cellules différenciées et que l’inhibition de voies de signalisation menant à la différenciation n’influence pas l’expression de ces marqueurs. Pour conclure, nous confirmons avoir dérivé des lignées de cellules semblables au cellules eES (eES-like) ne correspondant pas complètement aux critères des cellules ES. / Embryonic stem (ES) cells carry high hopes for biomedical research in order to provide definitive treatment for osteoarthritis. The horse is considered to be an important animal model for examining osteoarthritis treatments. However, despite almost thirty years of research, authentic equine ES (eES) cells have not yet been derived. In this context, the main objective of this study was to derive eES cell lines. The first objective of our study was to optimize the technique for deriving eES cells. We show that different feeder cell lines and embryo development stages influence the effectiveness of this technique while the use of cell signalling inhibitors does not influence eES cell derivation. The second objective was to characterize markers of pluripotency and differentiation in eES cell lines by RT-PCR. We demonstrate that the eES cells express both markers associated with pluripotent cells and differentiated cells and that the presence of cell signalling inhibitors in the culture medium does not influence the expression of these markers. In conclusion, we confirm having derived eES-like cells but these do not meet all the molecular criteria of authentic ES cells.

Guanylyl cyclase C (GC-C) is a member of particulate guanylyl cyclases, discovered primarily as the target of a family of heat stable enterotoxins (ST), produced by enterotoxigenic Escherichia coli (ETEC). ST is acknowledged as a prime cause of traveller’s diarrhea and the leading cause of child mortality under the age of 5 years in developing nations. The bacterial expression of ST peptides represents molecular mimicry where the pathogen has exploited a gastrointestinal tract-signaling pathway to disperse and propagate. GC-C is primarily expressed on the apical or the brush border membranes of intestinal epithelial cells. GC-C agonists elaborated in the gastrointestinal tract are a family of guanylin peptides, which are responsible for maintaining fluid-ion homeostasis, essential for normal gut physiology. The signal of liigand binding to the extracellular domain of GC-C is transduced to the catalytic guanylyl cyclase domain, which results in production of intracellular cGMP. The elevated levels of cGMP influence multiple downstream targets, which finally regulate ion-flux through the transporters present on the membrane of an enterocyte. The ST peptide, a GC-C superagonist, produces physiologically abnormal levels of cGMP that manifest as secretory diarrhea. The purview of GC-C misregulation was confined to the notion of its hyperactivation caused by ETEC infection and the ensuing diarrhea. Recently, two seminal studies widened the scope of pathologies associated with GC-C. Studies described point mutations in GUCY2C, which were associated with human disease. One study identified a Norwegian family whose members demonstrated a dominantly inherited syndrome of frequent diarrhea associated with hyperactive GC-C. Following this study, inactivating mutations in GC-C in a small Bedouin population was reported. The current study reports the molecular phenotypes associated with the first germ line mutations in GC-C that result in a severe form of congenital sodium diarrhea. Our collaborators from Austria (Thomas Muller & Andreas Janecke, Department of Pediatrics Innsbruck Medical University) communicated to us their study of patients who had clinical diagnosis of congenital sodium diarrhea, with proportionally high fecal sodium loss, metabolic acidosis and dehydration. Exome sequencing in a cohort of 6 unrelated patients revealed four heterozygous missense mutations in GC-C (R792S, L775P, K507E, N850D). Novel GC-C mutations were de novo spontaneous mutations with the carrier being the only affected family member in contrast to the previous two reports with familial history. Biochemical characterization revealed that the mutants (GC-CR792S, GC-CL775P) were constitutively active with GC-CR792S, GC-CK507E, and GC-CN850D showing further stimulation upon treatment with ST and guanylin family of peptides. Interestingly, there was no change in the binding affinities of the ligands for the mutant receptors compared to wild type. However, a significant decrease (ranging from 10-100 fold) in ligand EC50 for the mutant GC-C receptors was prominent. The in vitro assays suggested that the mutations occupying different domains of GC-C might have resulted in distinct structural consequences reflected in the repertoire of phenotypes that were observed. The results presented in this thesis illustrate the molecular basis of the severe form of congenital diarrhea associated with the GC-C gain-of-function mutations. This study has also elaborated our understanding of the regulation of GC-C activity by its various domains.

No description available.

Le gène par-4 code pour une kinase à sérine/thréonine très conservée qui régule la polarisation précoce et la division cellulaire asymétrique de l’embryon de C. elegans. Une mutation de par-4 entraîne la létalité embryonnaire en perturbant trois processus: la ségrégation asymétrique des déterminants cellulaires, la régulation asynchrone de la progression du cycle cellulaire et la contractilité du réseau d’actomyosine. Pour identifier des régulateurs des voies de signalisation de PAR-4, nous avons procédé à un criblage pour des suppresseurs de la létalité embryonnaire associée à une mutation de par-4. Nous avons identifié 6 gènes qui codent pour des homologues conservés avec des activités définies telles que la phosphorylation, l’ubiquitination, la protéolyse et l’échafaudage. En employant l’imagerie quantitative pour suivre des événements cellulaires dépendants de PAR-4, nous avons déterminé quels processus sont contrôlés par chaque suppresseur durant le développement embryonnaire de C. elegans. Des analyses moléculaires de ces suppresseurs ont révélé des détails sur le mécanisme par lequel PAR-4 régule la polarisation cellulaire et promeut la division cellulaire asymétrique. / The gene lkb1 codes for a highly conserved serine/threonine kinase. The orthologue of lkb1 in the nematode Caeonorhabditis elegans, termed par-4, regulates early polarization and asymmetric cell division in the embryo. A mutation in par-4 causes embryonic lethality by perturbing three main cellular processes: asymmetric segregation of cell fate determinants, asynchronic regulation of cell cycle progression and contractility of the actomyosin network. To identify regulators of the PAR-4/LKB1-dependent pathways, we performed a screen for suppressors of the embryonic lethality associated with a mutation in par-4. We identified 6 genes that have conserved homologs with defined activities including protein phosphorylation, ubiquitination, proteolysis and scaffolding. We used quantitative imaging of specific PAR-4-dependent cellular events to determine which of these are controlled by each suppressor during early C. elegans embryonic development. Molecular analysis of these suppressors revealed details on the mechanism through which PAR-4 regulates cell polarization and promotes asymmetric cell division.

<strong>Background:</strong> Our laboratory identified ELTD1, an orphan GPCR belonging to the adhesion GPCR family (aGPCR), as a novel regulator of angiogenesis and a potential anti-cancer therapeutic target. ELTD1 is normally expressed in both endothelial cells and vascular smooth muscle cells and expression is significantly increased in the tumour vasculature. The aim of this project was to analyse ELTD1's function in endothelial cells and its role in breast cancer. <strong>Method:</strong> 62 sequenced vertebrate genomes were interrogated for ELTD1 conservation and domain alterations. A phylogenetic timetree was assembled to establish time estimates for ELTD1's evolution. After ELTD1 silencing, mRNA array profiling was performed on primary human umbilical vein endothelial cells (HUVECs) and validated with qPCR and confocal microscopy. ELTD1's signalling was investigated by applying the aGPCR ‘Stinger/tethered-agonist Hypothesis'. For this, truncated forms of ELTD1 and peptides analogous to the proposed tethered agonist region were designed. FRET-based 2^nd messenger (Cisbio IP-1;cAMP) and luciferase-reporter assays (NFAT; NFÎoB; SRE; SRF-RE; CREB) were performed to establish canonical GPCR activation. To further investigate ELTD1's role in endothelial cells, ELTD1 was stably overexpressed in HUVECS. Functional angiogenesis assays and mRNA array profiling were then performed. To investigate ELTD1 in breast cancer, a panel of cell lines representative of all molecular subtypes were screened using qPCR. Furthermore, an exploratory pilot study was performed on matched primary and regional nodal secondary breast cancers (n=43) which were stained for ELTD1 expression. Staining intensity was then scored and compared with relapse free survival and overall survival. <strong>Results:</strong> ELTD1 arose 435 million years ago (mya) in bony fish and is present in all subsequent vertebrates. ELTD1 has 3 evolutionary variants of which 2 are most common: one variant with 3 EGFs and a variant with 2 EGFs. Additionally, ELTD1 may be ancestral to members of aGPCR family 2. HUVEC mRNA expression profiling after ELTD1 silencing showed upregulation of the mitochondrial citrate transporter SLC25A1, and ACLY which converts cytoplasmic citrate to Acetyl CoA, feeding fatty acid and cholesterol synthesis, and acetylation. A review of lipid droplet (fatty acid and cholesterol) accumulation by confocal microscopy and flow cytometry (FACS) revealed no changes with ELTD1 silencing. Silencing was also shown to affect the Notch pathway (downregulating the Notch ligand JAG1 and target gene HES2; upregulating the Notch ligand DLL4) and inducing KIT, a mediator of haematopoietic (HSC) and endothelial stem cell (ESC) maintenance. Signalling experiments revealed that unlike other aGPCRs, ELTD1 does not couple to any canonical GPCR pathways (Gαi, Gαs, Gαq, Gα12/13). ELTD1 overexpression in HUVECS revealed that ELTD1 induces an endothelial tip cell phenotype by promoting sprouting and capillary formation, inhibiting lumen anastomoses in mature vessels and lowering proliferation rate. There was no effect on wound healing or adhesion to angiogenesis associated matrix components. Gene expression changes following ELTD1 overexpression included upregulation of angiogenesis associated ANTRX1 as well as JAG1 and downregulation of migration associated CCL15 as well as KIT and DLL4. In breast cancer, none of the representative breast cancer cell lines screened expressed ELTD1. ELTD1 breast cancer immunohistochemistry revealed higher levels of vascular ELTD1 staining intensity within the tumour stroma contrasted to normal stroma and expression within tumour epithelial cells. Additionally, ELTD1 expression in tumour vessels was differentially expressed between the primary breast cancer microenvironment and that of the matched regional node. Due to the small size of the pilot study population, survival comparisons between the various subgroups did not yield significant results. <strong>Conclusion:</strong> ELTD1 is a novel regulator of endothelial metabolism through its suppression of ACLY and the related citrate transporter SLC25A1. ELTD1 also represses KIT, which is known to mediate haematopoietic and endothelial progenitors stem cell maintenance, a possible mechanism through which endothelial cells maintain terminal endothelial differentiation. ELTD1 does not signal like other adhesion GPCRS with CTF and FL forms of ELTD1 not signalling canonically. Additionally, ELTD1 regulates various functions of endothelial cell behaviour and function, inducing an endothelial tip cell phenotype and is highly evolutionarily conserved. Lastly, ELTD1 is differentially expressed in tumour vessels between primary breast cancer and regional nodal metastases and is also expressed in a small subset of breast cancer cells in vivo despite no cancer cell lines expressing ELTD1. The pilot study investigating ELTD1 in the primary breast cancer and regional involved nodes will be followed up with a larger study including the investigation of ELTD1 in distant metastases.

Calcium (Ca2+) ist ein in eukaryotischen Zellen allgegenwärtiger sekundärer Botenstoff. Durch Inositoltrisphosphat (IP3) ausgelöste Ca2+-Signale von IP3-Rezeptoren (IP3Rs) sind eines der universellsten Zell Signalübertragungssysteme. Ca2+ Signale sind fundamental stochastisch. Dennoch hat sich die Modellierung dieser Ca2+-Signale bisher stark auf deterministische Ansätze mit gewöhnlichen Differentialgleichungen gestützt. Diese wurden als Ratengleichungen etabliert und beruhen auf räumlich gemitteltem Ca2+ Werten. Diese Ansätze vernachlässigen Rauschen und Zufall. In dieser Dissertation präsentieren wir ein stochastisches Modell zur Erzeugung von Ca2+ Spikes in Form einer linearen Zustands-Kette. Die Anzahl offener Cluster ist die Zustandsvariable und Erholung von negativem Feedback wird berücksichtigt. Wir identifizieren einen Ca2+ Spike mit dem ersten Erreichen eines kritischen Zustands und sein Interspike Intervall mit der first-passage time (FPT) zu diesem Zustand. Dafür entwickeln wir einen allgemeinen mathematischen Rahmen zur analytischen Berechnung von FPTs auf solch einer Kette. Wir finden z.B. einen allgemein verringerten CV, der ein deutliches Minimum in Abhängigkeit der Zustandskettenlänge N aufweist. Dies nennen wir resonante Länge. Danach ergänzen wir positives Feedback und wenden das Modell auf verschiedene Zelltypen an. Es erfasst alle verfügbaren allgemeinen Beobachtungen zu Ca2+ Signalvorgängen. Es erlaubt uns Einblicke in den Zusammenhang von Agonistenstärke und Puffraten. Auch werden einzelne Ca2+ Spikes in Purkinje Neuronen, welche eine Rolle für Lernen und Erinnerung spielen, als stochastisches reaction-diffusion Model in einer 3D Dornenfortsatz Geometrie modelliert. Ataxia, eine Krankheit, die zum Verlust der Feinmotorik führt, wird auf defekte IP3R zurückgeführt, die abnormale Ca2+ Spikes erzeugen. Dieser Zustand wird ebenfalls untersucht und es wird ein Weg zur Wiederherstellung normaler Ca2+ Spikes vorgeschlagen. / Calcium (Ca2+) is a ubiquitous 2nd messenger molecule in all eukaryotic cells. Inositol trisphosphate (IP3)-induced Ca2+ signalling via IP3 receptors (IP3Rs) is one of the most universal signalling systems used by cells to transmit information. Ca2+ signalling is noisy and a fundamentally stochastic system. Yet, modelling of IP3-induced Ca2+ signalling has relied heavily on deterministic approaches with ordinary differential equations in the past, established as rate equations using spatially averaged Ca2+. These approaches neglect the defining features of Ca2+ signalling, noise and fluctuations. In this thesis, we propose a stochastic model of Ca2+ spike generation in terms of a linear state chain with the number of open clusters as its state variable, also including recovery from negative feedback. We identify a Ca2+ spike with reaching a critical state for the first time, and its interspike interval with the first passage time to that state. To this end, a general mathematical framework for analytically computing first-passage times of such a linear chain is developed first. A substantially reduced CV with a pronounced minimum, dependent on the chain length N, termed resonant length, are found. Positive feedback is then included into the model, and it is applied directly to various cell types. The model is fundamentally stochastic and successfully captures all available general observations on Ca2+ signalling. Also, we specifically study single Ca2+ spikes in spines of Purkinje neurons, assumed to be important for motor learning and memory, using MCell to simulate a reaction-diffusion system in a complex 3D Purkinje spine geometry. The model successfully reproduces experimentally findings on properties of Ca2+ spikes. Ataxia, a pathological condition resulting in, e.g., a loss of fine motor control, assumed to be caused by malfunctioning IP3Rs, is modelled and a possible way of recovery is suggested.